期刊文献+

妊娠肝内胆汁淤积症胎盘细胞凋亡与Fas、FasL的研究 被引量:18

Study on Apoptosis and Expression of Fas, FasL in Placenta of Intrahepatic Cholestasis of Pregnancy
原文传递
导出
摘要 目的 探讨妊娠肝内胆汁淤积症 (intrahepatic cholestasis of pregnancy,ICP)胎盘组织Fas及 Fas L (Fasligand)表达在细胞凋亡中的作用。 方法 采用 d U TP缺口末端标记法 (TU NEL )和免疫组化技术对 31例 ICP患者胎盘组织中的细胞凋亡、Fas、Fas L的基因表达进行检测 ,并以正常妊娠胎盘组织 31例作为对照组。 结果  ICP组胎盘组织中细胞滋养细胞、合体滋养细胞、蜕膜细胞及绒毛间质细胞的凋亡指数 (AI)分别为 4 9.0 9± 9.13(t=13.4 1)、4 6 .6 4± 9.77(t=12 .16 )、35 .0 9±9.4 9(t=8.4 3)、38.74± 9.70 (t=11.2 8) ,明显高于对照组 (P<0 .0 0 5 )。 ICP组细胞滋养细胞和合体滋养细胞 Fas表达明显增强 (P<0 .0 0 5 ) ,Fas L在细胞滋养细胞、合体滋养细胞、蜕膜细胞及绒毛间质细胞中的表达明显低于对照组 (P<0 .0 0 5 )。 结论  ICP患者胎盘组织中 Fas表达增强 ,Fas L表达减弱 ,可导致母胎间免疫耐受的破坏 ,胎盘细胞凋亡增加 ,可能与 ICP患者胎盘功能减退有关。 Objective To study the role of gene Fas and FasL expression in apoptosis of plcenta with ICP. Methods TUNEL (TdT-mediated dUTP nick end labeling) and immuno-hisochemistry methods were used for 31 placental samples with ICP and 31 normal placental samples to detect apoptosis index (AI) and the expression of Fas and FasL in placental tissues. Results AI of cytotrophoblast, syncytotrophoblast, decidual cells and mediate cell(49.09±9.13,t=13.41;46.64±9.77,t=12.16;35.09±9.49,t=8.43;38.74±9.70,t=11.28) in ICP group was significantly higher than that of control group (P<0.005). The expression of FasL of these positions in ICP group was lower than that in control group (P<0.005) The expression of Fas in cytotrophoblast and syncytotrophoblast of ICP group were higher than that in control group (P<0.005). Conclusions Abnormal expression of Fas and FasL in placental tissue may destroy the immunologic tolerance between the mother and the fetus and the increasing apoptosis of placenta may relate to the placental dysfunction.
出处 《中华围产医学杂志》 CAS 2003年第4期199-201,共3页 Chinese Journal of Perinatal Medicine
关键词 妊娠并发症 肝内胆汁淤积症 胎盘 细胞凋亡 Fas FASL TUNEL 免疫组化技术 Pregnancy complications Cholestasis, intrahepatic Placenta Apoptosis Antigens,CD95 Membrane proteins
  • 相关文献

参考文献9

  • 1刘伯宁 沈宁 等.妊娠肝内胆汁淤积症胎盘的组织计量测定[J].中华妇产科杂志,1988,23(1):9-9.
  • 2Bamberger AM, Schulte HM, Thuneke I, et al. Expression of apoptosis inducing Fas ligand in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab,1997,82 : 3173-3175.
  • 3Axt R, Kordina AC, Meyberg R, et al. Immunohistochemical evaluation of apoptosis in pacentae from normal and intrauterine growth restricted pregnancies. Clin Exp Obstet Gynecol, 1999,26:195-198.
  • 4Alsulyman OM, Ouzounian JG, Ames-Castro M, et al. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol, 1996,175:957-960.
  • 5Kokawa K, Shikone T, Nakano R. Apoptosis in the human uterine endocrinology during the menstrual cycle. J Clin Endocrinol Metab, 1996,81 : 4144-4147.
  • 6Nelson DM. Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrinoid is deposited at discontinuties in the villous trophoblast. Placenta,1996,17:387-391.
  • 7Balkundi DR, Hanna N, Hileb M, et al. Labor-associated changs in Fas ligand expression and function in human placenta.Pediatr Res, 2000,47 : 301-308.
  • 8Hetts SW. To die or not to die : An overview of apoptosis and its role in diease. JAMA, 1998,297 : 300-307.
  • 9Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science, 1995,270:1189-1192.

共引文献22

同被引文献162

引证文献18

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部